• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Cell & Gene Therapy

ocean covering up money lost investment
Favicon Fierce Biotech

Novo ends all cell therapy R&D, lets go of staff

Novo is looking for partners to further develop its cell therapy programs, a spokesperson told Fierce Biotech.
Gabrielle Masson Oct 10, 2025 3:30pm
Biopharma biotech biotech industry biopharma industry science microscope DNA double helix

Regulatory, policy uncertainties harm biopharma planning: Cytiva

Oct 8, 2025 3:11pm
cardboard box with office belongings and a desk chair
Favicon Fierce Biotech

Big pharma cuts and gene therapy woes: Inside Q3's layoffs

Oct 3, 2025 4:30pm
newspaper

Novo-KBP, Takeda, Enhertu—Fierce Pharma Asia

Oct 2, 2025 4:02pm
photo of a number of hands in the center

Fresenius launches group to propel CAR-T production in Europe

Aug 28, 2025 9:34am
calendar

Sarepta extends $700M debt to 2030 amid Elevidys uncertainty

Aug 21, 2025 10:52am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings